John Scribner > Weil, Gotshal & Manges LLP > Washington DC, United States > Lawyer Profile

Weil, Gotshal & Manges LLP
2001 M STREET, NW, SUITE 600
United States

Work Department





John Scribner represents clients on their most significant antitrust merger matters. He has played a lead role in obtaining FTC and DOJ regulatory approval for antitrust-sensitive transactions in numerous industries and possesses significant experience in the high-tech and pharmaceutical space. He has successfully managed the antitrust review process for complex, global transactions that were subject to in-depth investigations in the US, EC, China, Korea, Japan, Brazil and Mexico. Prior to Weil, Mr. Scribner was with the FTC and was involved in merger and non-merger investigations in a wide range of industries, including defense, pharmaceuticals, aviation, energy, industrial products, medical devices and high-tech. While at the FTC, he received the Award for Superior Service and the Award for Meritorious Service.

Lawyer Rankings

United States > Antitrust > Merger control

Weil, Gotshal & Manges LLP offers a destination merger and antitrust practice, working with top clients including Microsoft, Walgreens, and Johnson & Johnson on high-value strategic mergers, often bet-the-company deals with significant multijurisdictional elements and facing significant regulatory scrutiny. The team offers a deep and focused bench with significant in-house agency expertise, with practice head Steven Newborn a former head of the FTC Mergers I Division with a strong reputation in complex merger proceedings, while Jeffrey Perry , Steven Bernstein , and Michael Moiseyev also held senior FTC positions. The firm has capabilities in key industry sectors including energy, technology, and pharma, and also regularly works with many of the wider firm’s private equity clients on strategic buyouts. Brianne Kucerik continues to establish herself as a top-level practitioner, handling a number of major deals facing DOJ and FTC oversight, and notably cleared MGM’s purchase of The Cosmopolitan casino for $1.6bn, while John Scribner has a strong record in the pharma and tech sectors, regularly advising Sanofi on transactions. Jeff White has seen a prolific 2021, particularly on behalf of major private equity funds and portfolio companies in various industries, while Vadim Brusser  was promoted to partner in January 2021 and heads up the firm’s HSR and merger regulatory practice, handling all aspects of global pre-merger issues. All lawyers mentioned are in Washington DC.